You are here: Industry Insights > approval

News List

Zydus Cadila gets US FDA nod to market generic HIV treatment tabs expressbpd
November 19, 2018
The product will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad
Lupin receives US FDA approval expressbpd
November 16, 2018
Lupin’s Decitabine for Injection, 50 mg/vial, Single-Dose Vial is indicated for the treatment of patients with myelodysplastic syndromes
Esco Medical secures CFDA approval for Embryo Incubators biospectrum
November 14, 2018
The fundamental design concept behind MIRI and MIRI TL improves upon the Silent Embryo Hypothesis by minimizing stressful factors that may be introduced when taking the dishes out of the incubator.
Pfizer snags OK for Xalkori follow-up Lorbrena in its 3rd cancer approval in 2 months fiercepharma
November 06, 2018
Pfizer’s oncology unit is on a roll. On Friday, the FDA approved its third cancer-fighter from the New York drugmaker in the past two months, setting it up to mount a double-barreled challenge in ALK-positive non-small cell lung cancer.
Sun Pharma bags receipt of European Commission approval expressbpd
September 20, 2018
The drug ILUMETRI (tildrakizumab) is indicated for the treatment of adults with moderate-to-severe chronic plaque psoriasis
Sun Pharma, SPARC Announce FDA Approval of Xelpros americanpharmaceuticalreview
September 18, 2018
Sun Pharmaceutical and Sun Pharma Advanced Research Company (SPARC) announced U.S. Food and Drug Administration (FDA) approval...
Lupin receives FDA approval for generic Atovaquone Oral Solution USP financialexpress
September 17, 2018
Lupin’s Atovaquone Oral Suspension USP, 750 mg/5 mL is the generic version of GlaxoSmithKline LLC’s Mepron Oral Suspension, 750 mg/5 mL
AstraZeneca gets further approval for Tagrisso in Japan pharmaphorum
August 22, 2018
AstraZeneca received approval from the Japanese regulator following a priority review of Tagrisso (osimertinib) as a first-line treatment of patients with positive non-small cell lung cancer (NSCLC), further expanding its currently authorised use in this
Pfizer announces EC approval of its oncology biosimilar biospectrumasia
August 06, 2018
The European Commission decision marks the approval of Pfizer’s first therapeutic oncology bio-similar.
FDA approves the first drug with an indication for treatment of smallpox europeanpharmaceuticalreview
July 19, 2018
The US Food and Drug Administration has approved TPOXX (tecovirimat), the first drug with an indication for treatment of smallpox…

Previous page 1 2 3 4 5 6 7 Next page